IIM
BMY icon

Intact Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Intact Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.57M Buy
148,700
+44,000
+42% +$2.53M 0.24% 96
2026
Q1 		$6.35M Sell
104,700
-1,400
-1% -$81.6K 0.18% 113
2025
Q4 		$5.72M Buy
106,100
+49,900
+89% +$2.4M 0.16% 121
2025
Q3 		$2.53M Hold
56,200
– – 0.08% 166
2025
Q2 		$2.6M Buy
56,200
+400
+0.7% +$19.6K 0.09% 173
2025
Q1 		$3.4M Hold
55,800
– – 0.12% 152
2024
Q4 		$3.16M Sell
55,800
-248,600
-82% -$13.9M 0.11% 166
2024
Q3 		$15.7M Buy
304,400
+20,200
+7% +$948K 0.52% 48
2024
Q2 		$11.8M Buy
284,200
+225,400
+383% +$10.1M 0.44% 51
2024
Q1 		$3.19M Hold
58,800
– – 0.13% 148
2023
Q4 		$3.02M Hold
58,800
– – 0.12% 153
2023
Q3 		$3.41M Hold
58,800
– – 0.15% 131
2023
Q2 		$3.76M Sell
58,800
-55,700
-49% -$3.74M 0.15% 134
2023
Q1 		$7.94M Sell
114,500
-74,500
-39% -$5.25M 0.33% 79
2022
Q4 		$13.6M Sell
189,000
-19,100
-9% -$1.44M 0.59% 41
2022
Q3 		$14.8M Buy
208,100
+400
+0.2% +$29K 0.49% 44
2022
Q2 		$16M Sell
207,700
-17,500
-8% -$1.33M 0.5% 45
2022
Q1 		$16.4M Sell
225,200
-15,100
-6% -$1.01M 0.42% 54
2021
Q4 		$15M Sell
240,300
-1,800
-0.7% -$106K 0.38% 59
2021
Q3 		$14.3M Buy
242,100
+4,600
+2% +$303K 0.4% 51
2021
Q2 		$15.9M Hold
237,500
– – 0.45% 50
2021
Q1 		$15M Buy
237,500
+55,700
+31% +$3.47M 0.45% 52
2020
Q4 		$11.3M Hold
181,800
– – 0.36% 60
2020
Q3 		$11M Buy
181,800
+49,700
+38% +$2.99M 0.38% 55
2020
Q2 		$7.76M Buy
132,100
+46,000
+53% +$2.75M 0.29% 75
2020
Q1 		$4.79M Buy
86,100
+33,200
+63% +$2.03M 0.21% 95
2019
Q4 		$3.39M Buy
52,900
+3,400
+7% +$195K 0.12% 138
2019
Q3 		$2.51M Sell
49,500
-5,000
-9% -$235K 0.09% 152
2019
Q2 		$2.47M Hold
54,500
– – 0.09% 144
2019
Q1 		$2.6M Sell
54,500
-26,800
-33% -$1.33M 0.09% 143
2018
Q4 		$4.22M Sell
81,300
-3,800
-4% -$204K 0.17% 106
2018
Q3 		$5.28M Buy
85,100
+3,000
+4% +$178K 0.19% 99
2018
Q2 		$4.54M Hold
82,100
– – 0.16% 103
2018
Q1 		$5.19M Buy
82,100
+75,200
+1,090% +$4.84M 0.2% 90
2017
Q4 		$423K Hold
6,900
– – 0.02% 164
2017
Q3 		$440K Hold
6,900
– – 0.02% 165
2017
Q2 		$384K Hold
6,900
– – 0.02% 178
2017
Q1 		$375K Sell
6,900
-6,800
-50% -$373K 0.02% 184
2016
Q4 		$801K Hold
13,700
– – 0.03% 166
2016
Q3 		$739K Buy
+13,700
New +$880K 0.03% 172

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Intact Investment Management's BMY Position: Q2 2026 in Review

Intact Investment Management increased its Bristol-Myers Squibb (BMY) stake by 42% in Q2 2026, buying an estimated $2.53M and bringing the position to 148,700 shares worth $8.57M. The position accounts for 0.24% of the portfolio, ranked #96.

Intact Investment Management first reported a position in BMY in Q3 2016 and has held it in 40 quarters since. The position peaked at $16.4M in Q1 2022. 830 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Intact Investment Management held 148,700 shares of Bristol-Myers Squibb worth $8.57M as of Q2 2026.
  • Intact Investment Management bought 44,000 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.53M.
  • Bristol-Myers Squibb made up 0.24% of Intact Investment Management's portfolio in Q2 2026, its #96 holding.
  • Intact Investment Management first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 40 quarters since.
  • Intact Investment Management's Bristol-Myers Squibb position peaked at $16.4M in Q1 2022.
  • 830 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.